Literature DB >> 26835397

Clinical and financial impact of HACs: a commentary on clinical and financial costs of hospital-acquired conditions.

Brian Branchford1.   

Abstract

Year:  2015        PMID： 26835397      PMCID： PMC4728998          DOI： 10.3978/j.issn.2224-4336.2015.10.06

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  9 in total

1.  Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research.

Authors:  Brian R Branchford; Elizabeth Gibson; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  Thromb Res       Date:  2011-11-21       Impact factor: 3.944

2.  A hospital-wide quality-improvement collaborative to reduce catheter-associated bloodstream infections.

Authors:  Derek S Wheeler; Mary Jo Giaccone; Nancy Hutchinson; Mary Haygood; Pattie Bondurant; Kathy Demmel; Uma R Kotagal; Beverly Connelly; Melinda S Corcoran; Kristin Line; Kate Rich; Pamela J Schoettker; Richard J Brilli
Journal:  Pediatrics       Date:  2011-09-19       Impact factor: 7.124

3.  Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit.

Authors:  Ernest K Amankwah; Christie M Atchison; Shilpa Arlikar; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg
Journal:  Thromb Res       Date:  2014-06-02       Impact factor: 3.944

4.  Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.

Authors:  Shilpa J Arlikar; Christie M Atchison; Ernest K Amankwah; Irmel A Ayala; Laurie A Barrett; Brian R Branchford; Michael B Streiff; Clifford M Takemoto; Neil A Goldenberg
Journal:  Thromb Res       Date:  2015-05-03       Impact factor: 3.944

Review 5.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

6.  Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

Authors:  Christie M Atchison; Shilpa Arlikar; Ernest Amankwah; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

7.  Surgical Site Infection Reduction by the Solutions for Patient Safety Hospital Engagement Network.

Authors:  Joshua K Schaffzin; Lory Harte; Scott Marquette; Karen Zieker; Sharyl Wooton; Kathleen Walsh; Jason G Newland
Journal:  Pediatrics       Date:  2015-10-05       Impact factor: 7.124

8.  Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation.

Authors:  Brian R Branchford; Peter Mourani; Lalit Bajaj; Marilyn Manco-Johnson; Michael Wang; Neil A Goldenberg
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

9.  Costs of Venous Thromboembolism, Catheter-Associated Urinary Tract Infection, and Pressure Ulcer.

Authors:  Anthony Goudie; Linda Dynan; Patrick W Brady; Evan Fieldston; Richard J Brilli; Kathleen E Walsh
Journal:  Pediatrics       Date:  2015-08-10       Impact factor: 7.124
  9 in total
  2 in total

1.  Pediatric Perioperative Clinical Pharmacy Practice: Clinical Considerations and Management: An Opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy.

Authors:  Elizabeth J Beckman; Sara Hovey; Deborah S Bondi; Gourang Patel; Richard H Parrish
Journal:  J Pediatr Pharmacol Ther       Date:  2022-08-19

2.  Editorial: Pediatric Venous Thromboembolism.

Authors:  Brian R Branchford; Julie Jaffray; Arash Mahajerin
Journal:  Front Pediatr       Date:  2018-09-27       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.